BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23255165)

  • 1. EMT markers in lung adenocarcinoma pleural effusion spheroid cells.
    Giarnieri E; De Vitis C; Noto A; Roscilli G; Salerno G; Mariotta S; Ricci A; Bruno P; Russo G; Laurenzi A; Giovagnoli MR; Ciliberto G; Mancini R
    J Cell Physiol; 2013 Aug; 228(8):1720-6. PubMed ID: 23255165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung.
    Ricci A; De Vitis C; Noto A; Fattore L; Mariotta S; Cherubini E; Roscilli G; Liguori G; Scognamiglio G; Rocco G; Botti G; Giarnieri E; Giovagnoli MR; De Toma G; Ciliberto G; Mancini R
    Cell Cycle; 2013 Jun; 12(11):1696-703. PubMed ID: 23656788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade.
    Chen SF; Lin YS; Jao SW; Chang YC; Liu CL; Lin YJ; Nieh S
    PLoS One; 2013; 8(5):e54659. PubMed ID: 23658677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slug regulates E-cadherin expression in metastatic adenocarcinoma cells isolated from pleural fluid.
    Li XN; Fang CQ; Wang YL; Wang XR; Wang EH; Li JH
    Diagn Cytopathol; 2013 Jan; 41(1):9-14. PubMed ID: 21656704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients.
    Zhao C; Li X; Su C; Li J; Cheng N; Ren S; Chen X; Zhou C
    Int J Clin Exp Pathol; 2015; 8(3):3104-9. PubMed ID: 26045824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment.
    Mancini R; Giarnieri E; De Vitis C; Malanga D; Roscilli G; Noto A; Marra E; Laudanna C; Zoppoli P; De Luca P; Affuso A; Ruco L; Di Napoli A; Mesiti G; Aurisicchio L; Ricci A; Mariotta S; Pisani L; Andreetti C; Viglietto G; Rendina EA; Giovagnoli MR; Ciliberto G
    PLoS One; 2011; 6(7):e21320. PubMed ID: 21789168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
    Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
    Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung.
    Kim S; Koh J; Kim MY; Kwon D; Go H; Kim YA; Jeon YK; Chung DH
    Hum Pathol; 2016 Dec; 58():7-14. PubMed ID: 27473266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factors related to epithelial mesenchymal transition in tumor center and margin in invasive lung adenocarcinoma.
    Maeng YI; Kim KH; Kim JY; Lee SJ; Sung WJ; Lee CK; Park JB; Park KK
    Int J Clin Exp Pathol; 2014; 7(7):4095-103. PubMed ID: 25120788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
    Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
    Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity.
    Roscilli G; De Vitis C; Ferrara FF; Noto A; Cherubini E; Ricci A; Mariotta S; Giarnieri E; Giovagnoli MR; Torrisi MR; Bergantino F; Costantini S; Fenizia F; Lambiase M; Aurisicchio L; Normanno N; Ciliberto G; Mancini R
    J Transl Med; 2016 Feb; 14():61. PubMed ID: 26928703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma.
    Sowa T; Menju T; Sonobe M; Nakanishi T; Shikuma K; Imamura N; Motoyama H; Hijiya K; Aoyama A; Chen F; Sato T; Kobayashi M; Yoshizawa A; Haga H; Sozu T; Date H
    Cancer Med; 2015 Dec; 4(12):1853-62. PubMed ID: 26471868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.
    Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH
    Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.
    Bruschini S; di Martino S; Pisanu ME; Fattore L; De Vitis C; Laquintana V; Buglioni S; Tabbì E; Cerri A; Visca P; Alessandrini G; Facciolo F; Napoli C; Trombetta M; Santoro A; Crescenzi A; Ciliberto G; Mancini R
    J Cell Physiol; 2020 Mar; 235(3):1877-1887. PubMed ID: 31397494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer.
    Chen X; Guan X; Zhang H; Xie X; Wang H; Long J; Cai T; Li S; Liu Z; Zhang Y
    J Exp Clin Cancer Res; 2015 Jan; 34(1):3. PubMed ID: 25609022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment.
    Yang D; Cao X; Wang F; Jiang H; Feng D; Guo H; Du L; Jin Y; Chen Y; Yin X; Li C
    Cancer Lett; 2017 Aug; 400():137-148. PubMed ID: 28461245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma.
    Shi Y; Wu H; Zhang M; Ding L; Meng F; Fan X
    Diagn Pathol; 2013 May; 8():89. PubMed ID: 23706092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
    Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
    Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.